Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kath Kerry

- PMLiVE

What Next?

Insights To Support Post Pandemic Heath Communications

- PMLiVE

The important role of CROs in shaping the future of clinical research across Europe

Looking at the impact of COVID-19 on clinical research activities

- PMLiVE

Be careful what you wish for

Ten months into this pandemic, it seems a lot of people are hoping for some strange things

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Impetus Digital

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Impetus Digital

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Impetus Digital

- PMLiVE

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health

If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...

OPEN Health

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Impetus Digital

- PMLiVE

The US celebrates five years of biosimilars on the market – a look to the past, present and future

Why the success of biosimilars in the US has been mixed

- PMLiVE

PMEA 2020: continuing to recognise excellence in improving patient outcomes

The 20th annual PMEAs took place virtually this year due to COVID-19

- PMLiVE

BMS’ Opdivo wins EU approval for second-line oesophageal cancer

Competition heats up with rival checkpoint inhibitor Keytruda

- PMLiVE

Russia says its Sputnik V COVID-19 vaccine is 91.4% effective

Preliminary data demonstrates efficacy of 95% after 42 days

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links